PSI
TXMD icon

Pinnacle Summer Investments’s TherapeuticsMD TXMD Stock Holding History

Pinnacle Summer Investments’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-100
Closed -$20K – 1024
2014
Q4 		$20K Buy
+100
New +$20.6K ﹤0.01% 663
2014
Q3 		– Sell
-600
Closed -$139K – 1093
2014
Q2 		$139K Buy
+600
New +$134K 0.02% 346

Other funds holding TXMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Pinnacle Summer Investments's TXMD Position: Q1 2015 in Review

Pinnacle Summer Investments sold out of TherapeuticsMD (TXMD) in Q1 2015, closing a stake of 100 shares — an estimated $20K sold.

Pinnacle Summer Investments first reported a position in TXMD in Q2 2014 and held it in 2 quarters. The position peaked at $139K in Q2 2014. 94 funds tracked by Wall St. Rank hold TXMD as of Q1 2015.

  • Pinnacle Summer Investments reported no remaining TherapeuticsMD position as of Q1 2015 after selling out during the quarter.
  • Pinnacle Summer Investments sold 100 TherapeuticsMD shares in Q1 2015, an estimated $20K.
  • Pinnacle Summer Investments first reported a position in TherapeuticsMD in Q2 2014 and held it in 2 quarters.
  • Pinnacle Summer Investments's TherapeuticsMD position peaked at $139K in Q2 2014.
  • 94 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2015.

Based on Pinnacle Summer Investments's 13F filing for Q1 2015, filed 19 May 2015.